Diagnostic HER2DX-guided treatment for patients with early-stage HER2-positive breast cancer.
CLINICAL RESEARCH WITH MEDICAL DEVICES
Clinical trial information
- Promoter: SOLTI
- Execution start: 16/10/24
- End of execution: 30/12/28
- IP: ISABEL BLANCAS LOPEZ-BARAJAS
